For the European Medicines Agency, a decade of challenges.
Rice
Mary
M
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology; D001688:Biological Products / Q000009:adverse effects / Q000494:pharmacology; D017277:Drug Approval; D005062:European Union; D006077:Government Agencies / Q000458:organization & administration; D006801:Humans; D007880:Legislation, Drug
D000970:Antineoplastic Agents; D001688:Biological Products